Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)
CNY 7.84
(0.38%)
CNY 7.84
(0.38%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.08 Billion CNY | -19.92% |
| 2022 | 2.6 Billion CNY | -5.46% |
| 2021 | 2.75 Billion CNY | 12.53% |
| 2020 | 2.44 Billion CNY | 21.53% |
| 2019 | 2.01 Billion CNY | 79.01% |
| 2018 | 1.12 Billion CNY | 2.21% |
| 2017 | 1.1 Billion CNY | 127.17% |
| 2016 | 484.36 Million CNY | 37.39% |
| 2015 | 352.53 Million CNY | -21.66% |
| 2014 | 450.03 Million CNY | 43.38% |
| 2013 | 313.86 Million CNY | 101.13% |
| 2012 | 156.05 Million CNY | 136.02% |
| 2011 | 66.11 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.35 Billion CNY | -6.42% |
| 2024 Q3 | 1.96 Billion CNY | -16.5% |
| 2024 Q1 | 2.51 Billion CNY | 20.53% |
| 2023 FY | 2.08 Billion CNY | -19.92% |
| 2023 Q3 | 2.86 Billion CNY | -1.16% |
| 2023 Q4 | 2.08 Billion CNY | -27.32% |
| 2023 Q2 | 2.9 Billion CNY | -4.21% |
| 2023 Q1 | 3.02 Billion CNY | 16.37% |
| 2022 Q3 | 2.95 Billion CNY | -3.19% |
| 2022 FY | 2.6 Billion CNY | -5.46% |
| 2022 Q4 | 2.6 Billion CNY | -11.88% |
| 2022 Q2 | 3.05 Billion CNY | 2.8% |
| 2022 Q1 | 2.96 Billion CNY | 7.79% |
| 2021 Q4 | 2.75 Billion CNY | 5.3% |
| 2021 FY | 2.75 Billion CNY | 12.53% |
| 2021 Q1 | 2.75 Billion CNY | 12.42% |
| 2021 Q2 | 2.6 Billion CNY | -5.27% |
| 2021 Q3 | 2.61 Billion CNY | 0.34% |
| 2020 Q4 | 2.44 Billion CNY | 0.42% |
| 2020 Q1 | 2.36 Billion CNY | 17.23% |
| 2020 Q2 | 2.41 Billion CNY | 2.49% |
| 2020 Q3 | 2.43 Billion CNY | 0.72% |
| 2020 FY | 2.44 Billion CNY | 21.53% |
| 2019 FY | 2.01 Billion CNY | 79.01% |
| 2019 Q3 | 1.93 Billion CNY | 16.88% |
| 2019 Q2 | 1.65 Billion CNY | -4.33% |
| 2019 Q4 | 2.01 Billion CNY | 3.8% |
| 2019 Q1 | 1.73 Billion CNY | 54.24% |
| 2018 Q4 | 1.12 Billion CNY | 7.69% |
| 2018 FY | 1.12 Billion CNY | 2.21% |
| 2018 Q3 | 1.04 Billion CNY | -1.89% |
| 2018 Q2 | 1.06 Billion CNY | -4.14% |
| 2018 Q1 | 1.11 Billion CNY | 0.92% |
| 2017 Q4 | 1.1 Billion CNY | 163.87% |
| 2017 Q1 | 417.36 Million CNY | -13.83% |
| 2017 Q2 | 417.21 Million CNY | -0.04% |
| 2017 Q3 | 417 Million CNY | -0.05% |
| 2017 FY | 1.1 Billion CNY | 127.17% |
| 2016 Q4 | 484.36 Million CNY | 228.88% |
| 2016 FY | 484.36 Million CNY | 37.39% |
| 2016 Q2 | 396.11 Million CNY | 24.02% |
| 2016 Q3 | 147.27 Million CNY | -62.82% |
| 2016 Q1 | 319.4 Million CNY | -9.4% |
| 2015 Q2 | 418.38 Million CNY | 0.0% |
| 2015 Q4 | 352.53 Million CNY | 9.54% |
| 2015 Q3 | 321.81 Million CNY | -23.08% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 352.53 Million CNY | -21.66% |
| 2014 Q4 | 450.03 Million CNY | 0.0% |
| 2014 FY | 450.03 Million CNY | 43.38% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 313.86 Million CNY | 101.13% |
| 2012 FY | 156.05 Million CNY | 136.02% |
| 2011 FY | 66.11 Million CNY | 0.0% |